Literature DB >> 2143858

Rapamycin in experimental renal allografts in dogs and pigs.

D S Collier1, R Calne, S Thiru, S Lim, S G Pollard, P Barron, M Da Costa, D J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2143858

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

Review 1.  mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.

Authors:  Andras Perl
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

Review 2.  Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols.

Authors:  R Indudhara; R B Khauli
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 3.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

4.  Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice.

Authors:  W L Baeder; J Sredy; S N Sehgal; J Y Chang; L M Adams
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Activation of the AKT and mammalian target of rapamycin pathways and the inhibitory effects of rapamycin on those pathways in canine malignant melanoma cell lines.

Authors:  Michael S Kent; Cameron J Collins; Fang Ye
Journal:  Am J Vet Res       Date:  2009-02       Impact factor: 1.156

6.  Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.

Authors:  Zhi-Wei Lai; Ryan Kelly; Thomas Winans; Ivan Marchena; Ashwini Shadakshari; Julie Yu; Maha Dawood; Ricardo Garcia; Hajra Tily; Lisa Francis; Stephen V Faraone; Paul E Phillips; Andras Perl
Journal:  Lancet       Date:  2018-03-15       Impact factor: 79.321

7.  Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs.

Authors:  Melissa C Paoloni; Christina Mazcko; Elizabeth Fox; Timothy Fan; Susan Lana; William Kisseberth; David M Vail; Kaylee Nuckolls; Tanasa Osborne; Samuel Yalkowsy; Daniel Gustafson; Yunkai Yu; Liang Cao; Chand Khanna
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

8.  Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs.

Authors:  Jeanne C Larson; Sara D Allstadt; Timothy M Fan; Chand Khanna; Paul J Lunghofer; Ryan J Hansen; Daniel L Gustafson; Alfred M Legendre; Gina D Galyon; Amy K LeBlanc; Tomas Martin-Jimenez
Journal:  Am J Vet Res       Date:  2016-01       Impact factor: 1.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.